Susquehanna International Group
RKDA icon

Susquehanna International Group’s Arcadia Biosciences RKDA Stock Holding History

Susquehanna International Group’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-721
Closed -$40K – 13789
2022
Q1 		$40K Buy
721
+180
+33% +$8.59K ﹤0.01% 12405
2021
Q4 		$22K Sell
541
-17
-3% -$1.11K ﹤0.01% 12813
2021
Q3 		$46K Sell
558
-783
-58% -$73.5K ﹤0.01% 12376
2021
Q2 		$159K Sell
1,341
-1,061
-44% -$116K ﹤0.01% 11807
2021
Q1 		$264K Buy
2,402
+1,896
+375% +$233K ﹤0.01% 10872
2020
Q4 		$51K Buy
+506
New +$61.8K ﹤0.01% 10748

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Susquehanna International Group's RKDA Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Arcadia Biosciences (RKDA) in Q1 2026: 12,614 shares worth $17.4K. The stake represents ﹤0.01% of the portfolio and ranks #12878 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in RKDA as recently as Q4 2022.

Susquehanna International Group first reported a position in RKDA in Q3 2018 and has held it in 11 quarters since. The position peaked at $461K in Q4 2020. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

  • Susquehanna International Group held 12,614 shares of Arcadia Biosciences worth $17.4K as of Q1 2026.
  • Arcadia Biosciences was a new Susquehanna International Group position in Q1 2026.
  • Arcadia Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12878 holding.
  • Susquehanna International Group first reported a position in Arcadia Biosciences in Q3 2018 and has held it in 11 quarters since.
  • Susquehanna International Group's Arcadia Biosciences position peaked at $461K in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.